{"id":"https://openalex.org/W2041367643","doi":"https://doi.org/10.1021/ml200053x","title":"N-Pyridyl and Pyrimidine Benzamides as KCNQ2/Q3 Potassium Channel Openers for the Treatment of Epilepsy","display_name":"N-Pyridyl and Pyrimidine Benzamides as KCNQ2/Q3 Potassium Channel Openers for the Treatment of Epilepsy","alternate_titles":[],"publication_year":2011,"publication_date":"2011-03-31","ids":{"openalex":"https://openalex.org/W2041367643","doi":"https://doi.org/10.1021/ml200053x","mag":"2041367643","pmid":"https://pubmed.ncbi.nlm.nih.gov/24900334","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/4018159"},"language":"en","primary_location":{"id":"doi:10.1021/ml200053x","doi":"https://doi.org/10.1021/ml200053x","is_oa":false,"landing_page_url":"https://doi.org/10.1021/ml200053x","pdf_url":null,"source":{"id":"https://openalex.org/S191852912","display_name":"ACS Medicinal Chemistry Letters","issn_l":"1948-5875","issn":["1948-5875"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-a","jufo-1","ki-jl-1","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320006","host_organization_name":"American Chemical Society","host_organization_lineage":["https://openalex.org/P4310320006"],"host_organization_lineage_names":["American Chemical Society"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"ACS Medicinal Chemistry Letters","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2041367643"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/4018159","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5073138621","display_name":"George S. Amato","orcid":"https://orcid.org/0000-0002-3512-1895","observed_orcids":["https://orcid.org/0000-0002-3512-1895"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"George Amato","raw_affiliation_strings":["Departments of \u2020Chemistry, \u2021Pharmacology, and \u00a7Biology, Icagen Inc., 4222 Emperor Boulevard, Durham, North Carolina 27702, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Departments of \u2020Chemistry, \u2021Pharmacology, and \u00a7Biology, Icagen Inc., 4222 Emperor Boulevard, Durham, North Carolina 27702, United States","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5085452913","display_name":"Rosemarie Roeloffs","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Rosemarie Roeloffs","raw_affiliation_strings":["Departments of \u2020Chemistry, \u2021Pharmacology, and \u00a7Biology, Icagen Inc., 4222 Emperor Boulevard, Durham, North Carolina 27702, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Departments of \u2020Chemistry, \u2021Pharmacology, and \u00a7Biology, Icagen Inc., 4222 Emperor Boulevard, Durham, North Carolina 27702, United States","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5086351035","display_name":"Greg C. Rigdon","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Greg C. Rigdon","raw_affiliation_strings":["Departments of \u2020Chemistry, \u2021Pharmacology, and \u00a7Biology, Icagen Inc., 4222 Emperor Boulevard, Durham, North Carolina 27702, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Departments of \u2020Chemistry, \u2021Pharmacology, and \u00a7Biology, Icagen Inc., 4222 Emperor Boulevard, Durham, North Carolina 27702, United States","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5043255288","display_name":"Brett M. Antonio","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Brett Antonio","raw_affiliation_strings":["Departments of \u2020Chemistry, \u2021Pharmacology, and \u00a7Biology, Icagen Inc., 4222 Emperor Boulevard, Durham, North Carolina 27702, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Departments of \u2020Chemistry, \u2021Pharmacology, and \u00a7Biology, Icagen Inc., 4222 Emperor Boulevard, Durham, North Carolina 27702, United States","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5040520336","display_name":"Theresa Mersch","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Theresa Mersch","raw_affiliation_strings":["Departments of \u2020Chemistry, \u2021Pharmacology, and \u00a7Biology, Icagen Inc., 4222 Emperor Boulevard, Durham, North Carolina 27702, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Departments of \u2020Chemistry, \u2021Pharmacology, and \u00a7Biology, Icagen Inc., 4222 Emperor Boulevard, Durham, North Carolina 27702, United States","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112449156","display_name":"Grant A. McNaughton-Smith","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Grant McNaughton-Smith","raw_affiliation_strings":["Departments of \u2020Chemistry, \u2021Pharmacology, and \u00a7Biology, Icagen Inc., 4222 Emperor Boulevard, Durham, North Carolina 27702, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Departments of \u2020Chemistry, \u2021Pharmacology, and \u00a7Biology, Icagen Inc., 4222 Emperor Boulevard, Durham, North Carolina 27702, United States","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5105777502","display_name":"Alan D. Wickenden","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Alan D. Wickenden","raw_affiliation_strings":["Departments of \u2020Chemistry, \u2021Pharmacology, and \u00a7Biology, Icagen Inc., 4222 Emperor Boulevard, Durham, North Carolina 27702, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Departments of \u2020Chemistry, \u2021Pharmacology, and \u00a7Biology, Icagen Inc., 4222 Emperor Boulevard, Durham, North Carolina 27702, United States","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5076978449","display_name":"Paul C. Fritch","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Paul Fritch","raw_affiliation_strings":["Departments of \u2020Chemistry, \u2021Pharmacology, and \u00a7Biology, Icagen Inc., 4222 Emperor Boulevard, Durham, North Carolina 27702, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Departments of \u2020Chemistry, \u2021Pharmacology, and \u00a7Biology, Icagen Inc., 4222 Emperor Boulevard, Durham, North Carolina 27702, United States","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5048342481","display_name":"Mark J. Suto","orcid":"https://orcid.org/0000-0003-0876-1210","observed_orcids":["https://orcid.org/0000-0003-0876-1210"]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"Mark J. Suto","raw_affiliation_strings":["Departments of \u2020Chemistry, \u2021Pharmacology, and \u00a7Biology, Icagen Inc., 4222 Emperor Boulevard, Durham, North Carolina 27702, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Departments of \u2020Chemistry, \u2021Pharmacology, and \u00a7Biology, Icagen Inc., 4222 Emperor Boulevard, Durham, North Carolina 27702, United States","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":["https://openalex.org/A5048342481"],"corresponding_institution_ids":[],"apc_list":{"value":4500,"currency":"USD","value_usd":4500},"apc_paid":null,"fwci":0.5752,"has_fulltext":false,"cited_by_count":55,"citation_normalized_percentile":{"value":0.59897279,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":86,"max":98},"biblio":{"volume":"2","issue":"6","first_page":"481","last_page":"484"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10493","display_name":"Ion channel regulation and function","score":0.8955000042915344,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10493","display_name":"Ion channel regulation and function","score":0.8955000042915344,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10094","display_name":"Epilepsy research and treatment","score":0.09719999879598618,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10274","display_name":"Heterocyclic Compound Synthesis and Bioactivity","score":0.002300000051036477,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/epilepsy","display_name":"epilepsy","score":0.6399999856948853},{"id":"https://openalex.org/keywords/structure-activity-relationship","display_name":"structure-activity relationship","score":0.9340000152587891},{"id":"https://openalex.org/keywords/antiepileptic-drugs","display_name":"antiepileptic drugs","score":0.6589999794960022},{"id":"https://openalex.org/keywords/pain-models","display_name":"pain models","score":0.4830000102519989}],"concepts":[{"id":"https://openalex.org/C2780231548","wikidata":"https://www.wikidata.org/wiki/Q417731","display_name":"Benzamide","level":2,"score":0.9277917146682739},{"id":"https://openalex.org/C2779321679","wikidata":"https://www.wikidata.org/wiki/Q207722","display_name":"Pyrimidine","level":2,"score":0.6134973168373108},{"id":"https://openalex.org/C2778186239","wikidata":"https://www.wikidata.org/wiki/Q41571","display_name":"Epilepsy","level":2,"score":0.5644999146461487},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.5543912649154663},{"id":"https://openalex.org/C83743174","wikidata":"https://www.wikidata.org/wiki/Q423778","display_name":"Potassium channel","level":2,"score":0.513177216053009},{"id":"https://openalex.org/C2777288759","wikidata":"https://www.wikidata.org/wiki/Q4164182","display_name":"Dosing","level":2,"score":0.4809419512748718},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.3600582480430603},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.35973748564720154},{"id":"https://openalex.org/C71240020","wikidata":"https://www.wikidata.org/wiki/Q186011","display_name":"Stereochemistry","level":1,"score":0.3553819954395294},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.18951523303985596},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.07257881760597229}],"mesh":[],"locations_count":4,"locations":[{"id":"doi:10.1021/ml200053x","doi":"https://doi.org/10.1021/ml200053x","is_oa":false,"landing_page_url":"https://doi.org/10.1021/ml200053x","pdf_url":null,"source":{"id":"https://openalex.org/S191852912","display_name":"ACS Medicinal Chemistry Letters","issn_l":"1948-5875","issn":["1948-5875"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-a","jufo-1","ki-jl-1","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320006","host_organization_name":"American Chemical Society","host_organization_lineage":["https://openalex.org/P4310320006"],"host_organization_lineage_names":["American Chemical Society"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"ACS Medicinal Chemistry Letters","raw_type":"journal-article"},{"id":"pmh:oai:europepmc.org:3020180","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/4018159","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":null,"raw_type":"Text"},{"id":"pmid:24900334","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/24900334","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"ACS medicinal chemistry letters","raw_type":"Journal Article"},{"id":"pmh:oai:pubmedcentral.nih.gov:4018159","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC4018159/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"ACS Med Chem Lett","raw_type":"Text"}],"best_oa_location":{"id":"pmh:oai:europepmc.org:3020180","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/4018159","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":null,"raw_type":"Text"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.8999999761581421,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":20,"referenced_works":["https://openalex.org/W1603834177","https://openalex.org/W1604195696","https://openalex.org/W1982638249","https://openalex.org/W1982816693","https://openalex.org/W1997537641","https://openalex.org/W2009134867","https://openalex.org/W2019959711","https://openalex.org/W2026064865","https://openalex.org/W2059690890","https://openalex.org/W2062463079","https://openalex.org/W2065880551","https://openalex.org/W2070032514","https://openalex.org/W2071335594","https://openalex.org/W2112272723","https://openalex.org/W2131128903","https://openalex.org/W2139032945","https://openalex.org/W2144432126","https://openalex.org/W2149307089","https://openalex.org/W2150315832","https://openalex.org/W2153629931"],"related_works":["https://openalex.org/W2139032945","https://openalex.org/W2153629931","https://openalex.org/W2799679819","https://openalex.org/W2803381080","https://openalex.org/W2094937027","https://openalex.org/W2037794099","https://openalex.org/W2041564747","https://openalex.org/W1982638249","https://openalex.org/W2010278844"],"abstract_inverted_index":{"A":[0],"series":[1],"of":[2,19,32,49,60,70,104],"N-pyridyl":[3],"benzamide":[4],"KCNQ2/Q3":[5,39],"potassium":[6],"channel":[7],"openers":[8],"were":[9],"identified":[10],"and":[11,21,35,51,85,107],"found":[12],"to":[13,101,108],"be":[14],"active":[15,44],"in":[16,45],"animal":[17],"models":[18,48],"epilepsy":[20,50],"pain.":[22],"The":[23],"best":[24],"compound":[25,42,105],"12":[26,106],"[ICA-027243,":[27],"N-(6-chloro-pyridin-3-yl)-3,4-difluoro-benzamide]":[28],"has":[29],"an":[30],"EC50":[31],"0.38":[33],"\u03bcM":[34],"is":[36],"selective":[37],"for":[38],"channels.":[40],"This":[41],"was":[43,83],"several":[46],"rodent":[47],"pain":[52],"but":[53],"upon":[54],"repeated":[55],"dosing":[56],"had":[57],"a":[58,77,88],"number":[59],"unacceptable":[61],"toxicities":[62],"that":[63,99],"prevented":[64],"further":[65],"development.":[66],"On":[67],"the":[68,71,96,102,109],"basis":[69],"structure-activity":[72,97],"relationships":[73,98],"developed":[74],"around":[75],"12,":[76],"second":[78],"compound,":[79],"51,":[80],"[N-(2-chloro-pyrimidin-5-yl)-3,4-difluoro-benzamide,":[81],"ICA-069673],":[82],"prepared":[84],"advanced":[86],"into":[87],"phase":[89],"1":[90],"clinical":[91],"study.":[92],"Herein,":[93],"we":[94],"describe":[95],"led":[100],"identification":[103],"corresponding":[110],"pyrimidine":[111],"51.":[112]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2041367643","counts_by_year":[{"year":2026,"cited_by_count":4},{"year":2025,"cited_by_count":3},{"year":2024,"cited_by_count":4},{"year":2023,"cited_by_count":4},{"year":2022,"cited_by_count":1},{"year":2021,"cited_by_count":6},{"year":2020,"cited_by_count":8},{"year":2019,"cited_by_count":4},{"year":2018,"cited_by_count":4},{"year":2017,"cited_by_count":4},{"year":2016,"cited_by_count":4},{"year":2015,"cited_by_count":3},{"year":2014,"cited_by_count":3},{"year":2013,"cited_by_count":2}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2016-06-24T00:00:00"}
